The spring campaign of Blue Diamond Stakes winner Samaready will be reviewed this weekend after the filly completes a course of treatment for a slight infection.
Samaready will miss Saturday’s Caulfield meeting, where she’d been entered for the McNeil Stakes, after being put on a course of antibiotics.
“She’s not too bad, but we can’t run on Saturday because she’s been treated,” trainer Mick Price said.
“But she hasn’t been quite right and we’ll have a look at things again at the weekend.”
Should her preparation continue, Samaready will run in the Group Two Danehill Stakes (1200m) at Flemington on October 8.
But her first major spring target, the $1 million Group One Golden Rose at Rosehill is off the filly’s agenda.
Price said he was under no pressure to continue with a spring campaign and would not be pushing on unless Samaready came through her setback in perfect order.
Samaready won her first four races, including the Blue Diamond, before finishing third in the Golden Slipper won by Pierro.
She resumed two weeks ago with a fourth behind Elite Elle over 1200m at Caulfield, a run that suggested she may have been slightly below par.
The first sign of any problem came when the filly went off her food early this week and missed a vital gallop on Tuesday as a result.